This could be attributed to the high expression of SLC7A11, which enhances the metabolic activity of neurons, leading to resistance to certain forms of damage; further research shows that high expression of SLC7A11 may also promote neuronal apoptosis and necrosis [128], contributing to the occurrence and development of neurodegenerative diseases. This evidence concerns the gene SLC7A11 and neurodegenerative disease.